Furthermore, tirzepatide stifles hunger and advances weight reduction, making it an important treatment choice for people with type 2 diabetes and stoutness
News provided by Nestl USA May 21, 2024, 09:00 ET The new product line consists of portion-aligned foods with high protein and essential nutrients ARLINGTON, Va., May 21, 2024 /PRNewswire/ -- Nestl is introducing Vital Pursuit, a new line of foods intended to be a companion for GLP-1 weight loss medication users and consumers focused on weight management

This includes individuals with: Diagnosed MASLD or MASH, where GLP-1 therapy may offer therapeutic benefits but requires monitoring Chronic viral hepatitis (hepatitis B or C), particularly if transaminases are elevated Autoimmune hepatitis or other inflammatory liver conditions Cirrhosis or advanced fibrosis, where specialist consultation may be appropriate despite generally not requiring dose adjustment History of drug-induced liver injury from other agents For these patients, baseline comprehensive liver assessmentincluding liver enzymes, synthetic function tests (albumin, INR), and potentially imaging or non-invasive fibrosis markers (such as FIB-4 or ELF)helps establish a reference point for monitoring treatment effects
SkinnyRx states this on its own website